Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.75 USD | -0.77% | -12.85% | +27.04% |
May. 15 | Solid Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.04% | 296M | |
+12.12% | 116B | |
+12.63% | 106B | |
-9.83% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-14.95% | 16.33B | |
+6.11% | 14.14B | |
+29.28% | 12.02B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Transcript : AavantiBio, Inc., Solid Biosciences Inc. - M&A Call